Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
Reported side effects in limited human use include mild nausea and dizziness
People who have previously experienced pancreatitis should monitor this and discuss the dangers with their doctors
BPC-157 upregulates angiogenic pathways (including VEGF) and counteracts inflammatory cytokines [3]
